Articles
Bird flu — the next pandemic?
Since 2013, nearly 800 people have contracted avian influenza, mostly from poultry markets, but the infection has ended there as it is unable to spread from person to person. [ + ]
Major genome release paves way for future biotech products
A major release of reference genomes is expected to pave the way for future health, biotechnology and agricultural products. [ + ]
Immunotherapy hope for BRCA1 breast cancer patients
A collaborative study by local scientists has potentially developed a new way to treat one of the most difficult forms of breast cancer. [ + ]
AACB Annual Scientific Conference
Leading international and local scientific experts will provide insights on current concepts and strategies to deliver the timely diagnostic services required for clinical management. [ + ]
Staying clinically competitive
Cost-competitiveness, high-quality data and fast study start-up times are some of the key factors that make Australia an attractive market for clinical trials. But as other countries strive to improve their clinical competitiveness, can Australia hold a dominant position? [ + ]
'Turning off' allergies
Researchers are one step closer to a treatment that could 'turn off' the immune response that causes common allergies, including asthma — which affects over two million Australians. [ + ]
Patenting biotech in Australia — an update
Obtaining a patent for a biotech invention is crucial to its further development and eventual commercialisation. Whether it's a new drug, insecticide or diagnostic, the developer needs to know they will have exclusive ownership of the invention and enjoy a return on their usually significant investment when they take the invention to the market. [ + ]
Australian Society For Microbiology 2017
The president of the Australian Society for Microbiology, ASN Conference organisers and the organising committee would like to invite you to stunning Tasmania for the 45th Annual Scientific Meeting and Trade Exhibition. The event will be held in Tasmania's capital city, Hobart, from 2–5 July. [ + ]
Researchers discover inflammatory 'dimmer switch'
Monash University researchers have uncovered how a group of proteins perform like a 'dimmer switch', causing inflammation ranging from acute to chronic. The findings could contribute to new treatments for inflammatory diseases including type 2 diabetes, atherosclerosis, heart attack and stroke.
[ + ]NHMRC restructures grant funding program
The National Health and Medical Research Council has restructured its grant program following a major review. [ + ]
Shining a light on microbial dark matter
Professor Philip Hugenholtz is a microbiologist with a particular interest in 'microbial dark matter' — the vast majority of microorganisms that have not be grown on an agar plate. [ + ]
Monash researchers discover key to 'superbug' antibiotic resistance
The World Health Organization recently issued a warning about the need to urgently develop new antibiotics to counter the growing threat of 'superbugs'. [ + ]
Weeding out malaria
The Menzies School of Health Research recommends a two-stage treatment for the notoriously difficult-to-cure Plasmodium vivax malaria, which has a similar approach to removing weeds from a garden bed. [ + ]
Chamber vs room monitoring: which temperature sensors are best for your application?
Electronic recording of temperatures with data stored in the cloud is pretty standard, but the choice of sensor type is often overlooked. [ + ]
Do painkillers cause heart attacks?
The latest research from Canada has found that regular use of even small amounts of over-the-counter painkillers can rapidly increase the risk of heart attack, but local experts suggest that the benefits can outweigh the risks in many cases. [ + ]